{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:56:51Z","timestamp":1792634211105,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01521","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T04:56:02Z","timestamp":1547009762000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":176,"title":["Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities"],"prefix":"10.3389","volume":"9","author":[{"given":"Dana","family":"Barchel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orit","family":"Stolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"De-Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomer","family":"Ziv-Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naama","family":"Saban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny Or","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Koren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matitiahu","family":"Berkovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"key":"B1","year":"2000","journal-title":"Diagnostic and Statistical Manual of Mental Disorders-IV-TR."},{"key":"B2","doi-asserted-by":"publisher","year":"2013","journal-title":"Diagnostic and Statistical Manual of Mental Disorders","DOI":"10.1176\/appi.books.9780890425596"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1038\/npp.2017.50","article-title":"The differential binding of antipsychotic drugs to the ABC transporter P-glycoprotein predicts cannabinoid-antipsychotic drug interactions.","volume":"42","author":"Brzozowska","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2147\/NDT.S1450","article-title":"Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents.","volume":"4","author":"Canitano","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/add.14145","article-title":"WHO World Mental Health Survey Collaborators: the associations between psychotic experiences, and substance use and substance use disorders: findings from the World Health Organisation World Mental Health Surveys.","volume":"113","author":"Degenhardt","year":"2018","journal-title":"Addiction"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-015-0586-5","article-title":"Marijuana use in epilepsy: the myth and the reality.","volume":"15","author":"Detyniecki","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4103\/1817-1745.174438","article-title":"Autism and sleep disorders.","volume":"10","author":"Devnani","year":"2015","journal-title":"J. Pediatr. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.neuron.2013.02.036","article-title":"Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoidsignaling.","volume":"78","author":"Foldy","year":"2013","journal-title":"Neuron"},{"key":"B10","year":"2004","journal-title":"MedDRA: Medical Dictionary for Regulatory Activities."},{"key":"B11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1023\/A:1005548619694","article-title":"Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.","volume":"30","author":"Handen","year":"2000","journal-title":"J. Autism Dev. Disord."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008372.pub2","article-title":"Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents.","volume":"14","author":"Hurwitz","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jns.2017.08.2623","article-title":"Oral cannabis extracts as a promising treatment for the core symptoms of autism spectrum disorder: preliminary experience in chilean patients.","volume":"381","author":"Kuester","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"B14","first-page":"4","article-title":"Use of dronabinol (delta-9-THC) in autism: a prospective single-case-study with an early infantile autistic child.","volume":"5","author":"Kurz","year":"2010","journal-title":"Cannabinoids"},{"key":"B15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/00952990.2011.643997","article-title":"Drug interactions between common illicit drugs and prescription therapies.","volume":"38","author":"Lindsey","year":"2012","journal-title":"Am. J. Drug Alcohol. Abuse"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.rasd.2013.09.006","article-title":"Comorbidity in autism spectrum disorder: a literature review.","volume":"7","author":"Mannion","year":"2013","journal-title":"Res. Autism Spectr. Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","article-title":"A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.","volume":"48","author":"Marcus","year":"2009","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1345\/aph.1D543","article-title":"Treating functional impairment of autism with selective serotonin-reuptake inhibitors.","volume":"38","author":"Moore","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s11920-010-0145-3","article-title":"Attention-deficit\/Hyperactivity disorder in the context of Autism spectrum disorders.","volume":"12","author":"Murray","year":"2010","journal-title":"Curr. Psychiatry Rep."},{"key":"B20","first-page":"79","article-title":"Short-term efficacy of CBD-enriched hemp oil in girls with dysautonomic syndrome after Human Papillomavirus Vaccination.","volume":"19","author":"Palmieri","year":"2017","journal-title":"Isr. Med. Assoc. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.pnpbp.2018.08.030","article-title":"Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.","volume":"89","author":"Poleg","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.yebeh.2013.08.037","article-title":"Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.","volume":"29","author":"Porter","year":"2013","journal-title":"Epilepsy Behav."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-016-9153-x","article-title":"Persistence of self-injurious behaviour in autism spectrum disorder over 3 years: a prospective cohort study of risk markers.","volume":"8","author":"Richards","year":"2016","journal-title":"J. Neurodev. Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/14740338.2017.1397128","article-title":"Drug-drug interactions as a result of co-administering \u03949-THC and CBD with other psychotropic agents.","volume":"17","author":"Rong","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.","volume":"163","author":"Russo","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ajp.2017.10.003","article-title":"Cannabis induced psychosis and subsequent psychiatric disorders.","volume":"30","author":"Shah","year":"2017","journal-title":"Asian J. Psychiatr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1007\/s10803-017-3322-y","article-title":"Anxiety and ASD: current progress and ongoing challenges.","volume":"47","author":"South","year":"2017","journal-title":"J. Autism Dev. Disord."},{"key":"B28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/AHMT.S9819","article-title":"Emerging role of aripiprazole for treatment of irritability associated with autistic disorder in children and adolescents.","volume":"15","author":"Stachnik","year":"2010","journal-title":"Adolesc. Health Med. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/03602532.2013.849268","article-title":"Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review.","volume":"46","author":"Stout","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1469-8749.2004.tb00503.x","article-title":"Autism spectrum disorders in children with normal intellectual levels: associated impairments and subgroups.","volume":"46","author":"Sturm","year":"2004","journal-title":"Dev. Med. Child Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10802-007-9165-9","article-title":"Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.","volume":"36","author":"Sukhodolsky","year":"2008","journal-title":"J. Abnorm. Child Psychol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"14084","DOI":"10.1073\/pnas.1509795112","article-title":"Endocannabinoid signaling mediates oxytocin-driven social reward.","volume":"112","author":"Wei","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40429-014-0018-7","article-title":"Impact of cannabis use on the development of psychotic disorders.","volume":"1","author":"Wilkinson","year":"2014","journal-title":"Curr. Addict. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1517\/14728214.2010.487860","article-title":"Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.","volume":"15","author":"Wink","year":"2010","journal-title":"Expert Opin. Emerg. Drugs"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01521\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T04:56:04Z","timestamp":1547009764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01521\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":34,"alternative-id":["10.3389\/fphar.2018.01521"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01521","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]},"article-number":"1521"}}